P2RX7B is a new theranostic marker for lung adenocarcinoma patients

Rationale: The characterization of new theranostic biomarkers is crucial to improving the clinical outcome of patients with advanced lung cancer. Here, we aimed at characterizing the P2RX7 receptor, a positive modulator of the anti-tumor immune response, in patients with lung adenocarcinoma. Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Benzaquen, Jonathan, Dit Hreich, Serena Janho, Heeke, Simon, Juhel, Thierry, Lalvee, Salomé, Bauwens, Serge, Saccani, Simona, Lenormand, Philippe, Hofman, Véronique, Butori, Mathilde, Leroy, Sylvie, Berthet, Jean-Philippe, Marquette, Charles-Hugo, Hofman, Paul, Vouret-Craviari, Valérie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532666/
https://www.ncbi.nlm.nih.gov/pubmed/33042257
http://dx.doi.org/10.7150/thno.48229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532666/
https://www.ncbi.nlm.nih.gov/pubmed/33042257
http://dx.doi.org/10.7150/thno.48229

Ejemplares similares